Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

NCT06931340 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1260

Enrollment

OTHER

Sponsor class

Conditions

Castration-Sensitive Prostate Carcinoma
Metastatic Prostate Adenocarcinoma
Stage IVB Prostate Cancer AJCC v8

Interventions

DRUG: Androgen Therapy
DRUG: Apalutamide
DRUG: Docetaxel
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Bone Scan
PROCEDURE: PSMA PET Scan
PROCEDURE: Biospecimen Collection
OTHER: Questionnaire Administration

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

National Cancer Institute (NCI)